Shinobu Wakamoto
Overview
Explore the profile of Shinobu Wakamoto including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
56
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
van der Meer P, Dumont L, Bondar N, Wong J, Ismay S, Pink J, et al.
Vox Sang
. 2014 Sep;
108(1):96-100.
PMID: 25234238
No abstract available.
2.
Wakamoto S, Fujihara M, Takahashi D, Niwa K, Sato S, Kato T, et al.
Transfusion
. 2010 Oct;
51(5):993-1001.
PMID: 20977481
Background: HLA Class II antibody-initiated activation of monocytes possessing the corresponding antigen is thought to participate in the pathogenesis of transfusion-related acute lung injury (TRALI). Pulmonary edema, a hallmark of...
3.
Yamaguchi M, Fujihara M, Wakamoto S, Sakai H, Takeoka S, Tsuchida E, et al.
ASAIO J
. 2009 Mar;
55(3):200-5.
PMID: 19282747
Hemoglobin vesicles (HbVs), liposomal oxygen carriers containing human hemoglobin, are candidates for development of a clinically useful transfusion alternative. Our previous in vivo animal studies of massive HbV dosages demonstrated...
4.
Wakamoto S, Fujihara M, Sakagawa H, Takahashi D, Niwa K, Morioka M, et al.
Transfusion
. 2008 Jun;
48(10):2060-8.
PMID: 18564388
Background: The generation of inflammatory mediators from monocytes activated by HLA Class II antibodies is thought to play important roles in the etiology of nonhemolytic transfusion reactions. Increased permeability of...
5.
Yamaguchi M, Fujihara M, Wakamoto S, Sakai H, Takeoka S, Tsuchida E, et al.
J Biomed Mater Res A
. 2008 Feb;
88(1):34-42.
PMID: 18257068
Hemoglobin vesicles (HbVs), liposomal oxygen carriers containing human hemoglobin, are candidates for development as clinically useful blood substitutes. Although HbVs are shown to distribute transiently into the bone marrow in...
6.
Komatsu T, Huang Y, Wakamoto S, Abe H, Fujihara M, Azuma H, et al.
J Biomed Mater Res A
. 2007 Jan;
81(4):821-6.
PMID: 17236218
Recombinant human serum albumin (HSA) including the synthetic iron(II)-porphyrin (FeP), albumin-heme (HSA-FeP), is a unique O(2)-carrying plasma hemoprotein as a red blood cell substitute. We have investigated the possible influence...
7.
Wakamoto S, Fujihara M, Abe H, Yamaguchi M, Azuma H, Ikeda H, et al.
Artif Cells Blood Substit Immobil Biotechnol
. 2005 Jun;
33(2):101-11.
PMID: 15960075
Hemoglobin vesicles (HbV) are artificial oxygen carriers that encapsulate a concentrated hemoglobin (Hb) solution with a phospholipid bilayer membrane. The oxygen transporting ability of HbV in vivo has been demonstrated...
8.
Morishita K, Wakamoto S, Miyazaki T, Sato S, Fujihara M, Kaneko S, et al.
Transfusion
. 2005 Apr;
45(5):803-6.
PMID: 15847672
Background: Anti-CD36 isoantibody in blood recipients is reported to cause refractoriness to platelet (PLT) transfusions and posttransfusion purpura-like syndrome. There are few reports, however, about the effects of passively transfused...
9.
Wakamoto S, Fujihara M, Kuzuma K, Sato S, Kato T, Naohara T, et al.
Transfusion
. 2003 Jul;
43(8):1038-46.
PMID: 12869108
Background: RANTES, one of the PLT-derived biologic response modifiers, accumulates in PLT concentrates (PCs) during storage and may play a causative role in nonhemolytic transfusion reactions (NHTRs) after PC transfusion....
10.
Ito T, Fujihara M, Oda A, Wakamoto S, Yamaguchi M, Komatsu N, et al.
Mol Cell Biochem
. 2003 Jul;
247(1-2):75-82.
PMID: 12841634
Thrombopoietin (TPO) is a hematopoietic cytokine that regulates megakaryocytosis and thrombocytosis by binding to its receptor (c-Mpl). The signaling pathways downstream of c-Mpl include the Ras/Raf/MAP kinase and JAK/STAT pathway...